United States · Funded startup

Who invested in MDMetrix

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2019, from 1 source

Latest round
Round, $3.0MMay 2019
Led by
Founders' Co-op
Investors
3 (1 led)
See who backed them

The rounds

  1. May 2019
    Round$3.0M

    Reported by GeekWireSEC filing: $3.1M sold, first sale Jun 2018

Founders and team

From the SEC filings it signed: 3 on the team.

  • Daniel LowExecutive Officer, Director, Promoteri
  • Matthew GoosExecutive Officer, Promoteri
  • Warren RatliffExecutive Officer, Director, Promoteri

On the board, as filediChristopher DeVore

Everyone who backed them

Founders' Co-opVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Quick answers about MDMetrix

Who invested in MDMetrix?

MDMetrix's investors include Founders' Co-op, Washington Research Foundation and Arnold Venture Group. Founders' Co-op led its latest round.

How much has MDMetrix raised?

MDMetrix has raised $3.0M across 1 round since 2019.

When did MDMetrix last raise?

MDMetrix's most recent round was an Undisclosed round of $3.0M in May 2019, led by Founders' Co-op.

What was MDMetrix's biggest round?

Its most recent round, $3.0M in May 2019, is also its largest on record.

Who backed MDMetrix first?

MDMetrix's first round on record, in May 2019, was backed by Founders' Co-op, Washington Research Foundation and Arnold Venture Group.

What stage is MDMetrix at?

MDMetrix's latest named round is an Undisclosed round, in May 2019.

Where is MDMetrix based?

MDMetrix is based in the United States.

Who led MDMetrix's rounds?

Founders' Co-op led the Undisclosed round in 2019.

Companies like MDMetrix

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.